{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:28:48Z","timestamp":1790994528348,"version":"4.1.0"},"reference-count":112,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003976","name":"Israel National Institute for Health Policy Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003976","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015652","name":"Barts Charity","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015652","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000833","name":"Rosetrees Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.bpobgyn.2020.01.006","type":"journal-article","created":{"date-parts":[[2020,2,4]],"date-time":"2020-02-04T19:24:09Z","timestamp":1580844249000},"page":"46-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Systematic review of acceptability, cardiovascular, neurological, bone health and HRT outcomes following risk reducing surgery in BRCA carriers"],"prefix":"10.1016","volume":"65","author":[{"given":"Faiza","family":"Gaba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjit","family":"Manchanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bpobgyn.2020.01.006_bib1","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am J Hum Genet"},{"issue":"11","key":"10.1016\/j.bpobgyn.2020.01.006_bib2","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","article-title":"Meta-analysis of BRCA1 and BRCA2 penetrance","volume":"25","author":"Chen","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"23","key":"10.1016\/j.bpobgyn.2020.01.006_bib3","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.bpobgyn.2020.01.006_bib4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/1471-2407-8-155","article-title":"Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: risks of breast\/ovarian cancer quoted should reflect the cancer burden in the family","volume":"8","author":"Evans","year":"2008","journal-title":"BMC Canc"},{"issue":"4","key":"10.1016\/j.bpobgyn.2020.01.006_bib5","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/AOG.0b013e3182864350","article-title":"Long-term mortality associated with oophorectomy compared with ovarian conservation in the nurses' health study","volume":"121","author":"Parker","year":"2013","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2020.01.006_bib6","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ejca.2014.11.022","article-title":"Bone mineral density and fractures after risk-reducing salpingo-oophorectomy in women at increased risk for breast and ovarian cancer","volume":"51","author":"Fakkert","year":"2015","journal-title":"Eur J Canc"},{"issue":"1","key":"10.1016\/j.bpobgyn.2020.01.006_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169673","article-title":"Elevated bone turnover markers after risk-reducing salpingo-oophorectomy in women at increased risk for breast and ovarian cancer","volume":"12","author":"Fakkert","year":"2017","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.bpobgyn.2020.01.006_bib8","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1258\/mi.2008.008016","article-title":"Prophylactic oophorectomy in premenopausal women and long-term health","volume":"14","author":"Shuster","year":"2008","journal-title":"Menopause Int"},{"issue":"11","key":"10.1016\/j.bpobgyn.2020.01.006_bib9","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1212\/01.wnl.0000276984.19542.e6","article-title":"Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause","volume":"69","author":"Rocca","year":"2007","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.bpobgyn.2020.01.006_bib10","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1212\/01.wnl.0000280573.30975.6a","article-title":"Increased risk of parkinsonism in women who underwent oophorectomy before menopause","volume":"70","author":"Rocca","year":"2008","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.bpobgyn.2020.01.006_bib11","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S1470-2045(06)70869-5","article-title":"Survival patterns after oophorectomy in premenopausal women: a population-based cohort study","volume":"7","author":"Rocca","year":"2006","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2020.01.006_bib12","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.gme.0000218683.97338.ea","article-title":"Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis","volume":"13","author":"Atsma","year":"2006","journal-title":"Menopause"},{"issue":"1","key":"10.1016\/j.bpobgyn.2020.01.006_bib13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/gme.0b013e31818888f7","article-title":"Increased cardiovascular mortality after early bilateral oophorectomy","volume":"16","author":"Rivera","year":"2009","journal-title":"Menopause"},{"issue":"4","key":"10.1016\/j.bpobgyn.2020.01.006_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2017.06.004","article-title":"Persistence of fimbrial tissue on the ovarian surface after salpingectomy","volume":"217","author":"Gan","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2020.01.006_bib15","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/PAS.0000000000000369","article-title":"Evidence for a dualistic model of high-grade serous carcinoma: BRCA mutation status, histology, and tubal intraepithelial carcinoma","volume":"39","author":"Howitt","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.bpobgyn.2020.01.006_bib16","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1158\/2159-8290.CD-16-0607","article-title":"Genomics of ovarian cancer progression reveals diverse metastatic trajectories including intraepithelial metastasis to the fallopian tube","volume":"6","author":"Eckert","year":"2016","journal-title":"Canc Discov"},{"issue":"1","key":"10.1016\/j.bpobgyn.2020.01.006_bib17","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1186\/1471-2458-13-756","article-title":"Public acceptability of government intervention to change health-related behaviours: a systematic review and narrative synthesis","volume":"13","author":"Diepeveen","year":"2013","journal-title":"BMC Publ Health"},{"key":"10.1016\/j.bpobgyn.2020.01.006_bib18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12889-015-2665-6","article-title":"Hungry for an intervention? Adolescents' ratings of acceptability of eating-related intervention strategies","volume":"16","author":"Stok","year":"2016","journal-title":"BMC Publ Health"},{"issue":"7262","key":"10.1016\/j.bpobgyn.2020.01.006_bib19","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1136\/bmj.321.7262.694","article-title":"Framework for design and evaluation of complex interventions to improve health","volume":"321","author":"Campbell","year":"2000","journal-title":"BMJ (Clinical research ed)"},{"key":"10.1016\/j.bpobgyn.2020.01.006_bib20","doi-asserted-by":"crossref","first-page":"a1655","DOI":"10.1136\/bmj.a1655","article-title":"Developing and evaluating complex interventions: the new Medical Research Council guidance","volume":"337","author":"Craig","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2020.01.006_bib21","first-page":"h1258","article-title":"Process evaluation of complex interventions: medical Research Council guidance","volume":"350","author":"Moore","year":"2015","journal-title":"BMJ Br Med J (Clin Res Ed)"},{"issue":"5","key":"10.1016\/j.bpobgyn.2020.01.006_bib22","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.ejca.2005.11.020","article-title":"Risk-reducing surgery in women with familial susceptibility for breast and\/or ovarian cancer","volume":"42","author":"Antill","year":"2006","journal-title":"Eur J Canc"},{"issue":"8","key":"10.1016\/j.bpobgyn.2020.01.006_bib23","first-page":"2318","article-title":"Uptake of risk-reducing surgery in unaffected women at high risk of breast and ovarian cancer is risk, age, and time dependent. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research","volume":"18","author":"Evans","year":"2009","journal-title":"Cospons Am Soc Prev Oncol"},{"issue":"11","key":"10.1016\/j.bpobgyn.2020.01.006_bib24","first-page":"875","article-title":"Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers","volume":"7","author":"Friebel","year":"2007","journal-title":"Clin Breast Canc"},{"issue":"1","key":"10.1016\/j.bpobgyn.2020.01.006_bib25","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.3747\/co.26.4068","article-title":"Selected medical interventions in women with a deleterious BRCA mutation: a population-based study in British Columbia","volume":"26","author":"Hanley","year":"2019","journal-title":"Curr Oncol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2020.01.006_bib26","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ygyno.2016.07.104","article-title":"Very high uptake of risk-reducing salpingo-oophorectomy in BRCA1\/2 mutation carriers: a single-center experience","volume":"143","author":"Harmsen","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"21","key":"10.1016\/j.bpobgyn.2020.01.006_bib27","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","article-title":"Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation","volume":"346","author":"Kauff","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.bpobgyn.2020.01.006_bib28","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/cge.12149","article-title":"Rates of risk-reducing surgery in Israeli BRCA1 and BRCA2 mutation carriers","volume":"85","author":"Laitman","year":"2014","journal-title":"Clin Genet"},{"issue":"28","key":"10.1016\/j.bpobgyn.2020.01.006_bib29","doi-asserted-by":"crossref","first-page":"6890","DOI":"10.1200\/JCO.2005.02.626","article-title":"Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer","volume":"23","author":"Madalinska","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2020.01.006_bib30","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41416-019-0446-1","article-title":"International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation","volume":"121","author":"Metcalfe","year":"2019","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.bpobgyn.2020.01.006_bib31","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1399-0004.2006.00665.x","article-title":"Risk-reducing surgery, screening and chemoprevention practices of BRCA1 and BRCA2 mutation carriers: a prospective cohort study","volume":"70","author":"Phillips","year":"2006","journal-title":"Clin Genet"},{"issue":"4","key":"10.1016\/j.bpobgyn.2020.01.006_bib32","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/bjc.2011.573","article-title":"Uptake of risk-reducing salpingo-oophorectomy in women carrying a BRCA1 or BRCA2 mutation: evidence for lower uptake in women affected by breast cancer and older women","volume":"106","author":"Sidon","year":"2012","journal-title":"Br J Cancer"},{"issue":"4","key":"10.1016\/j.bpobgyn.2020.01.006_bib33","doi-asserted-by":"crossref","first-page":"329.e1","DOI":"10.1016\/j.ajog.2013.01.026","article-title":"Impact of family history on choosing risk-reducing surgery among BRCA mutation carriers","volume":"208","author":"Singh","year":"2013","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2020.01.006_bib34","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1399-0004.2009.01329.x","article-title":"Risk-reducing mastectomy and salpingo-oophorectomy in unaffected BRCA mutation carriers: uptake and timing","volume":"77","author":"Skytte","year":"2010","journal-title":"Clin Genet"},{"issue":"1","key":"10.1016\/j.bpobgyn.2020.01.006_bib35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/gtmb.2008.0067","article-title":"Uptake, time course, and predictors of risk-reducing surgeries in BRCA carriers","volume":"13","author":"Beattie","year":"2009","journal-title":"Genet Test Mol Biomarkers"},{"issue":"3","key":"10.1016\/j.bpobgyn.2020.01.006_bib36","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/ajmg.a.10102","article-title":"Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing","volume":"118a","author":"Botkin","year":"2003","journal-title":"Am J Med Genet"},{"issue":"3","key":"10.1016\/j.bpobgyn.2020.01.006_bib37","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/GIM.0b013e318163487d","article-title":"Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers","volume":"10","author":"Bradbury","year":"2008","journal-title":"Genet Med : Off J Am Coll Med Genetic"},{"issue":"2","key":"10.1016\/j.bpobgyn.2020.01.006_bib38","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10549-014-3134-0","article-title":"Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriers","volume":"148","author":"Chai","year":"2014","journal-title":"Breast Canc Res Treat"},{"issue":"13","key":"10.1016\/j.bpobgyn.2020.01.006_bib39","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1002\/cncr.30621","article-title":"Racial disparities in BRCA testing and cancer risk management across a population-based sample of young breast cancer survivors","volume":"123","author":"Cragun","year":"2017","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.bpobgyn.2020.01.006_bib40","article-title":"Satisfaction and impact on quality of life of clinical and instrumental surveillance and prophylactic surgery in BRCA-mutation carriers","volume":"18","author":"D'Alonzo","year":"2018","journal-title":"Clin Breast Canc"},{"issue":"12","key":"10.1016\/j.bpobgyn.2020.01.006_bib41","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1200\/JCO.2011.37.8133","article-title":"Breast and ovarian cancer risk and risk reduction in Jewish BRCA1\/2 mutation carriers","volume":"30","author":"Finkelman","year":"2012","journal-title":"J\u00a0Clin Oncol : Off J Am Soc Clini Oncol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2020.01.006_bib42","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/tbj.12521","article-title":"Surgical decision making in the BRCA-positive population: institutional experience and comparison with recent literature","volume":"22","author":"Flippo-Morton","year":"2016","journal-title":"Breast J"},{"issue":"2","key":"10.1016\/j.bpobgyn.2020.01.006_bib43","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ygyno.2013.12.014","article-title":"Risk management options elected by women after testing positive for a BRCA mutation","volume":"132","author":"Garcia","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2020.01.006_bib44","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00432-015-2051-x","article-title":"Uptake of risk-reducing salpingo-oophorectomy among female BRCA mutation carriers: experience at the National Cancer Center of Korea","volume":"142","author":"Kim","year":"2016","journal-title":"J\u00a0Canc Res Clin Oncol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2020.01.006_bib45","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s10689-006-0002-z","article-title":"Acceptance of preventive surgeries by Israeli women who had undergone BRCA testing","volume":"5","author":"Kram","year":"2006","journal-title":"Fam Cancer"},{"issue":"7","key":"10.1016\/j.bpobgyn.2020.01.006_bib46","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1007\/s00268-010-0477-5","article-title":"Choice of management of southern Chinese BRCA mutation carriers","volume":"34","author":"Kwong","year":"2010","journal-title":"World J Surg"},{"issue":"1","key":"10.1016\/j.bpobgyn.2020.01.006_bib47","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1006\/pmed.2000.0684","article-title":"Prophylactic surgery decisions and surveillance practices one year following BRCA1\/2 testing","volume":"31","author":"Lerman","year":"2000","journal-title":"Prev Med"},{"issue":"2","key":"10.1016\/j.bpobgyn.2020.01.006_bib48","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1023\/A:1015269620265","article-title":"One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery)","volume":"73","author":"Lodder","year":"2002","journal-title":"Breast Canc Res Treat"},{"issue":"1","key":"10.1016\/j.bpobgyn.2020.01.006_bib49","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ygyno.2017.02.008","article-title":"Factors associated with deciding between risk-reducing salpingo-oophorectomy and ovarian cancer screening among high-risk women enrolled in GOG-0199: an NRG Oncology\/Gynecologic Oncology Group study","volume":"145","author":"Mai","year":"2017","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2020.01.006_bib50","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1471-0528.2011.03257.x","article-title":"Factors influencing uptake and timing of risk reducing salpingo-oophorectomy in women at risk of familial ovarian cancer: a competing risk time to event analysis","volume":"119","author":"Manchanda","year":"2012","journal-title":"BJOG"},{"issue":"9220","key":"10.1016\/j.bpobgyn.2020.01.006_bib51","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0140-6736(00)02347-3","article-title":"Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation","volume":"355","author":"Meijers-Heijboer","year":"2000","journal-title":"Lancet (London, England)"},{"issue":"2","key":"10.1016\/j.bpobgyn.2020.01.006_bib52","first-page":"e92","article-title":"Variation in rates of uptake of preventive options by Canadian women carrying the BRCA1 or BRCA2 genetic mutation","volume":"1","author":"Metcalfe","year":"2007","journal-title":"Open Med : A Peer-review Indepen Open-access J"},{"issue":"11","key":"10.1016\/j.bpobgyn.2020.01.006_bib53","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1136\/jmg.37.11.866","article-title":"An evaluation of needs of female BRCA1 and BRCA2 carriers undergoing genetic counselling","volume":"37","author":"Metcalfe","year":"2000","journal-title":"J\u00a0Med Genet"},{"issue":"3","key":"10.1016\/j.bpobgyn.2020.01.006_bib54","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10689-012-9527-5","article-title":"The consequences of risk reducing salpingo-oophorectomy: the case for a coordinated approach to long-term follow up post surgical menopause","volume":"11","author":"Pezaro","year":"2012","journal-title":"Fam Cancer"},{"issue":"6","key":"10.1016\/j.bpobgyn.2020.01.006_bib55","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s10897-005-5833-5","article-title":"Risk-reduction surgery decisions in high-risk women seen for genetic counseling","volume":"14","author":"Ray","year":"2005","journal-title":"J\u00a0Genet Counsel"},{"issue":"2","key":"10.1016\/j.bpobgyn.2020.01.006_bib56","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/cncr.26294","article-title":"Long-term outcomes of BRCA1\/BRCA2 testing: risk reduction and surveillance","volume":"118","author":"Schwartz","year":"2012","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.bpobgyn.2020.01.006_bib57","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1006\/gyno.2002.6737","article-title":"Psychological impact of prophylactic oophorectomy in women at increased risk of developing ovarian cancer: a prospective study","volume":"86","author":"Tiller","year":"2002","journal-title":"Gynecol Oncol"},{"issue":"12","key":"10.1016\/j.bpobgyn.2020.01.006_bib58","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1002\/cncr.22352","article-title":"Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study","volume":"107","author":"Uyei","year":"2006","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.bpobgyn.2020.01.006_bib59","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1002\/cncr.25820","article-title":"Satisfaction with ovarian carcinoma risk-reduction strategies among women at high risk for breast and ovarian carcinoma","volume":"117","author":"Westin","year":"2011","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.bpobgyn.2020.01.006_bib60","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ejhg.2010.241","article-title":"Cancer risk management strategies and perceptions of unaffected women 5 years after predictive genetic testing for BRCA1\/2 mutations","volume":"19","author":"Julian-Reynier","year":"2011","journal-title":"Eur J Hum Genet : EJHG (Eur J Hum Genet)"},{"issue":"1","key":"10.1016\/j.bpobgyn.2020.01.006_bib61","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ygyno.2018.04.564","article-title":"Bilateral salpingectomy with delayed oophorectomy for ovarian cancer risk reduction: a pilot study in women with BRCA1\/2 mutations","volume":"150","author":"Nebgen","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2020.01.006_bib62","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ygyno.2014.02.030","article-title":"Acceptability of prophylactic salpingectomy with delayed oophorectomy as risk-reducing surgery among BRCA mutation carriers","volume":"133","author":"Holman","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"8","key":"10.1016\/j.bpobgyn.2020.01.006_bib63","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1158\/1055-9965.EPI-09-0171","article-title":"Uptake of risk-reducing surgery in unaffected women at high risk of breast and ovarian cancer is risk, age, and time dependent","volume":"18","author":"Evans","year":"2009","journal-title":"Canc Epidemiol Biomarkers Prev"},{"issue":"3","key":"10.1016\/j.bpobgyn.2020.01.006_bib64","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ygyno.2015.06.020","article-title":"Osteoporosis risk and management in BRCA1 and BRCA2 carriers who undergo risk-reducing salpingo-oophorectomy","volume":"138","author":"Garcia","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.bpobgyn.2020.01.006_bib65","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1471-0528.2011.03257.x","article-title":"Factors influencing uptake and timing of risk reducing salpingo- oophorectomy in women at risk of familial ovarian cancer: a competing risk time to event analysis","volume":"119","author":"Manchanda","year":"2012","journal-title":"BJOG An Int J Obstet Gynaecol"},{"issue":"3 Pt 1","key":"10.1016\/j.bpobgyn.2020.01.006_bib66","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/01.AOG.0000228959.30577.13","article-title":"Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations","volume":"108","author":"Schmeler","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"953","key":"10.1016\/j.bpobgyn.2020.01.006_bib67","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/pgmj.2004.026237","article-title":"Access to health care for ethnic minority populations","volume":"81","author":"Szczepura","year":"2005","journal-title":"Postgrad Med"},{"issue":"3","key":"10.1016\/j.bpobgyn.2020.01.006_bib68","doi-asserted-by":"crossref","first-page":"E33","DOI":"10.1097\/NCC.0b013e3182642cb5","article-title":"Understanding the needs of women considering risk-reducing salpingo-oophorectomy","volume":"36","author":"Cherry","year":"2013","journal-title":"Canc Nurs"},{"issue":"9","key":"10.1016\/j.bpobgyn.2020.01.006_bib69","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1038\/bjc.2011.120","article-title":"Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers","volume":"104","author":"Metcalfe","year":"2011","journal-title":"Br J Cancer"},{"issue":"12","key":"10.1016\/j.bpobgyn.2020.01.006_bib70","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1200\/JCO.2004.04.033","article-title":"Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers","volume":"22","author":"Metcalfe","year":"2004","journal-title":"J\u00a0Clin Oncol : Off J Am Soc Clini Oncol"},{"issue":"4","key":"10.1016\/j.bpobgyn.2020.01.006_bib71","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s10689-015-9825-9","article-title":"Risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a 30-year semi-prospective analysis","volume":"14","author":"Basu","year":"2015","journal-title":"Fam Cancer"},{"issue":"9","key":"10.1016\/j.bpobgyn.2020.01.006_bib72","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality","volume":"304","author":"Domchek","year":"2010","journal-title":"J\u00a0Am Med Assoc: J Am Med Assoc"},{"issue":"3","key":"10.1016\/j.bpobgyn.2020.01.006_bib73","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1470-2045(06)70585-X","article-title":"Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study","volume":"7","author":"Domchek","year":"2006","journal-title":"Lancet Oncol"},{"issue":"26","key":"10.1016\/j.bpobgyn.2020.01.006_bib74","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1200\/JCO.2012.45.3571","article-title":"Ten-year survival in patients with BRCA1-negative and BRCA1-positive breast cancer","volume":"31","author":"Huzarski","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.bpobgyn.2020.01.006_bib75","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/jamaoncol.2015.0658","article-title":"Effect of oophorectomy on survival after breast cancer in BRCA1 and BRCA2 mutation carriers","volume":"1","author":"Metcalfe","year":"2015","journal-title":"JAMA oncol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2020.01.006_bib76","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ygyno.2011.04.004","article-title":"Surveillance of survivors: follow-up after risk-reducing salpingo-oophorectomy in BRCA 1\/2 mutation carriers","volume":"122","author":"Chapman","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2020.01.006_bib77","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10689-011-9480-8","article-title":"Non-cancer endpoints in BRCA1\/2 carriers after risk-reducing salpingo-oophorectomy","volume":"11","author":"Cohen","year":"2012","journal-title":"Fam Cancer"},{"issue":"6","key":"10.1016\/j.bpobgyn.2020.01.006_bib78","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/IGC.0b013e3181a83cd5","article-title":"Fatigue and quality of life after risk-reducing salpingo-oophorectomy in women at increased risk for hereditary breast-ovarian cancer","volume":"19","author":"Michelsen","year":"2009","journal-title":"Int J Gynecol Canc : Off J Inter Gynecolo Cancer Soc"},{"issue":"3","key":"10.1016\/j.bpobgyn.2020.01.006_bib79","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ygyno.2018.01.013","article-title":"Bone loss in women with BRCA1 and BRCA2 mutations","volume":"148","author":"Powell","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2020.01.006_bib80","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/bjc.2011.202","article-title":"Menopausal symptoms and bone health in women undertaking risk reducing bilateral salpingo-oophorectomy: significant bone health issues in those not taking HRT","volume":"105","author":"Challberg","year":"2011","journal-title":"Br J Cancer"},{"issue":"3 Pt 2","key":"10.1016\/j.bpobgyn.2020.01.006_bib81","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/gme.0b013e31804c793d","article-title":"Effect of early menopause on bone mineral density and fractures","volume":"14","author":"Gallagher","year":"2007","journal-title":"Menopause (New York, NY)"},{"issue":"5","key":"10.1016\/j.bpobgyn.2020.01.006_bib82","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/AOG.0b013e3181a11c64","article-title":"Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses' health study","volume":"113","author":"Parker","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2020.01.006_bib83","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/1479-5876-11-201","article-title":"The clinical utility of bone marker measurements in osteoporosis","volume":"11","author":"Wheater","year":"2013","journal-title":"J\u00a0Transl Med"},{"issue":"12","key":"10.1016\/j.bpobgyn.2020.01.006_bib84","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/clc.7","article-title":"Metabolic syndrome and cardiovascular disease: challenges and opportunities","volume":"30","author":"Cooper-DeHoff","year":"2007","journal-title":"Clin Cardiol"},{"issue":"10","key":"10.1016\/j.bpobgyn.2020.01.006_bib85","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1001\/archinte.164.10.1066","article-title":"Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women","volume":"164","author":"Hu","year":"2004","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.bpobgyn.2020.01.006_bib86","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/archinte.163.4.427","article-title":"The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994","volume":"163","author":"Park","year":"2003","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.bpobgyn.2020.01.006_bib87","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ygyno.2008.02.025","article-title":"Bilateral oophorectomy before 50 years of age is significantly associated with the metabolic syndrome and Framingham risk score: a controlled, population-based study (HUNT-2)","volume":"109","author":"D\u00f8rum","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2020.01.006_bib88","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/GIM.0b013e31815f524f","article-title":"A\u00a0systematic review of perceived risks, psychological and behavioral impacts of genetic testing","volume":"10","author":"Heshka","year":"2008","journal-title":"Genet Med"},{"issue":"1","key":"10.1016\/j.bpobgyn.2020.01.006_bib89","first-page":"87","article-title":"Age as a risk factor","volume":"96","author":"Dhingra","year":"2012","journal-title":"Med Clin"},{"issue":"2","key":"10.1016\/j.bpobgyn.2020.01.006_bib90","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/IGC.0b013e3181ca5ff4","article-title":"Coronary heart disease risk profile in women who underwent salpingo-oophorectomy to prevent hereditary breast ovarian cancer","volume":"20","author":"Michelsen","year":"2010","journal-title":"Int J Gynecol Canc : Off J Inter Gynecolo Cancer Soc"},{"issue":"1","key":"10.1016\/j.bpobgyn.2020.01.006_bib91","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejca.2008.09.028","article-title":"Metabolic syndrome after risk-reducing salpingo-oophorectomy in women at high risk for hereditary breast ovarian cancer: a controlled observational study","volume":"45","author":"Michelsen","year":"2009","journal-title":"Eur J Canc"},{"issue":"5","key":"10.1016\/j.bpobgyn.2020.01.006_bib92","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1212\/01.WNL.0000046523.05125.87","article-title":"Caffeine, postmenopausal estrogen, and risk of Parkinson's disease","volume":"60","author":"Ascherio","year":"2003","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.bpobgyn.2020.01.006_bib93","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1212\/WNL.62.11.2010","article-title":"Risk of Parkinson disease in women: effect of reproductive characteristics","volume":"62","author":"Ragonese","year":"2004","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.bpobgyn.2020.01.006_bib94","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1097\/GME.0000000000000724","article-title":"Use of systemic hormone therapy in BRCA mutation carriers","volume":"23","author":"Domchek","year":"2016","journal-title":"Menopause"},{"issue":"19","key":"10.1016\/j.bpobgyn.2020.01.006_bib95","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/jnci\/djn313","article-title":"Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers","volume":"100","author":"Eisen","year":"2008","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.bpobgyn.2020.01.006_bib96","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/13697137.2016.1209396","article-title":"Hormone therapy after prophylactic risk-reducing bilateral salpingo-oophorectomy in women who have BRCA gene mutation","volume":"19","author":"Guidozzi","year":"2016","journal-title":"Climacteric : J Inter Menopause Soc"},{"issue":"8","key":"10.1016\/j.bpobgyn.2020.01.006_bib97","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jamaoncol.2018.0211","article-title":"Hormone replacement therapy after oophorectomy and breast cancer risk among BRCA1 mutation carriers","volume":"4","author":"Kotsopoulos","year":"2018","journal-title":"JAMA Oncol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2020.01.006_bib98","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10549-016-3685-3","article-title":"Hormone replacement therapy after menopause and risk of breast cancer in BRCA1 mutation carriers: a case-control study","volume":"155","author":"Kotsopoulos","year":"2016","journal-title":"Breast Canc Res Treat"},{"issue":"31","key":"10.1016\/j.bpobgyn.2020.01.006_bib99","doi-asserted-by":"crossref","first-page":"7804","DOI":"10.1200\/JCO.2004.00.8151","article-title":"Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group","volume":"23","author":"Rebbeck","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2020.01.006_bib100","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12905-017-0370-6","article-title":"The effect of hormone therapy on quality of life and breast cancer risk after risk-reducing salpingo-oophorectomy: a systematic review","volume":"17","author":"Siyam","year":"2017","journal-title":"BMC Wom Health"},{"issue":"3","key":"10.1016\/j.bpobgyn.2020.01.006_bib101","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"issue":"9382","key":"10.1016\/j.bpobgyn.2020.01.006_bib102","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(03)14065-2","article-title":"Breast cancer and hormone-replacement therapy in the million women study","volume":"362","author":"Beral","year":"2003","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.bpobgyn.2020.01.006_bib103","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.maturitas.2015.12.004","article-title":"The effects of pre-operative menopausal status and hormone replacement therapy (HRT) on sexuality and quality of life after risk-reducing salpingo-oophorectomy","volume":"85","author":"Tucker","year":"2016","journal-title":"Maturitas"},{"issue":"22","key":"10.1016\/j.bpobgyn.2020.01.006_bib104","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1200\/JCO.2005.05.1896","article-title":"The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy","volume":"24","author":"Madalinska","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2020.01.006_bib105","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ygyno.2010.12.326","article-title":"The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation","volume":"121","author":"Finch","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.bpobgyn.2020.01.006_bib106","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/pon.2041","article-title":"The impact of prophylactic salpingo-oophorectomy on quality of life and psychological distress in women with a BRCA mutation","volume":"22","author":"Finch","year":"2013","journal-title":"Psycho Oncol"},{"issue":"6","key":"10.1016\/j.bpobgyn.2020.01.006_bib107","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1365-2265.2010.03868.x","article-title":"Physiological versus standard sex steroid replacement in young women with premature ovarian failure: effects on bone mass acquisition and turnover","volume":"73","author":"Crofton","year":"2010","journal-title":"Clin Endocrinol"},{"issue":"11","key":"10.1016\/j.bpobgyn.2020.01.006_bib108","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1359\/jbmr.1997.12.11.1851","article-title":"Premenopausal ovariectomy-related bone loss: a randomized, double-blind, one-year trial of conjugated estrogen or medroxyprogesterone acetate","volume":"12","author":"Prior","year":"1997","journal-title":"J\u00a0Bone Miner Res : Off J Am Soc Bone Mineral Res"},{"issue":"8","key":"10.1016\/j.bpobgyn.2020.01.006_bib109","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1210\/jc.2004-0015","article-title":"Impaired endothelial function in young women with premature ovarian failure: normalization with hormone therapy","volume":"89","author":"Kalantaridou","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metabol"},{"issue":"2","key":"10.1016\/j.bpobgyn.2020.01.006_bib110","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.maturitas.2005.04.009","article-title":"The association between early menopause and risk of ischaemic heart disease: influence of Hormone Therapy","volume":"53","author":"Lokkegaard","year":"2006","journal-title":"Maturitas"},{"issue":"1","key":"10.1016\/j.bpobgyn.2020.01.006_bib111","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ygyno.2015.11.016","article-title":"Sexual activity and functioning after risk-reducing salpingo-oophorectomy: impact of hormone replacement therapy","volume":"140","author":"Johansen","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.bpobgyn.2020.01.006_bib112","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejca.2017.07.018","article-title":"Hormone replacement therapy after risk-reducing salpingo-oophorectomy minimises endocrine and sexual problems: a prospective study","volume":"84","author":"Vermeulen","year":"2017","journal-title":"Eur J Canc"}],"container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693420300183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693420300183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:11:14Z","timestamp":1761498674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693420300183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":112,"alternative-id":["S1521693420300183"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2020.01.006","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic review of acceptability, cardiovascular, neurological, bone health and HRT outcomes following risk reducing surgery in BRCA carriers","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2020.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}